Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NIFTY: Onivyde in metastatic biliary tract cancer
NCT03524508Phase 2Completed
- Start
- Sep 2018
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan liposome injection in biliary tract cancer (BTC). Started Sep 2018; status: completed.
02
Drugs
irinotecan liposome injection
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT03524508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03524508.